XEN 45 Gel Stent Implantation in Open Angle Glaucoma: 5-Year Results of a Prospective Study

被引:5
|
作者
Torbey, Julien [1 ]
Paillard, Archibald [1 ]
Rao, Harsha L. [2 ]
Gillman, Kevin [1 ]
Bravetti, Giorgio E. [1 ]
Mermoud, Andre [1 ]
Mansouri, Kaweh [1 ,3 ,4 ]
机构
[1] Glaucoma Res Ctr, Montchoisi Clin, Swiss Visio Network, Lausanne, Switzerland
[2] Narayana Nethralaya, Hulimavu, Bangalore, India
[3] Univ Colorado, Sch Med, Dept Ophthalmol, Denver, CO USA
[4] Montchoisi Clin, Swiss Visio Glaucoma Res Ctr, Ave Servan 38, CH-1006 Lausanne, Switzerland
关键词
glaucoma; microinvasive glaucoma surgery (MIGS); XEN 45 gel stent; surgery; open angle; anterior segment; INTRAOCULAR-PRESSURE; PHACOEMULSIFICATION; SURGERY;
D O I
10.1097/IJG.0000000000002302
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Pr & eacute;cis: XEN 45 Gel Stent is safe and effective for 3 years. The study results provide useful insight into the outcome of XEN 45 Gel Stent surgery over 5 years in daily clinical practice.Purpose: To evaluate 5-year outcomes of XEN 45 gel stent implantation (XEN) in patients with open angle glaucoma.Methods: This is a prospective, single-center, interventional study. XEN implantation either alone (XEN) or combined with phacoemulsification (Phaco + XEN) was performed on 170 consecutive eyes (126 patients) with uncontrolled intraocular pressure (IOP) or disease progression despite medical treatment. "Complete" surgical success at 60 months was defined as unmedicated IOP <= 15 mm Hg and a relative IOP reduction >= 20% from medicated baseline, while "qualified" success allowed fewer ocular hypotensive medications than at baseline. Other definitions of success with various IOP targets were also analyzed. Secondary outcomes included mean IOP and IOP-lowering medication changes and rates of reoperations.Results: Mean age was 78.1 +/- 9.2 years, and 70.3% were female. Mean medicated IOP decreased from 19.8 +/- 7.7 mm Hg [19.6 +/- 7.1 (XEN) vs. 19.8 +/- 7.0 mm Hg (Phaco+XEN)] at baseline to 12.6 +/- 3.1 mm Hg [12.5 +/- 3.1 (XEN) vs. 12.6 +/- 3.1 (Phaco+XEN)] at 5 years (-37.0%; P < 0.001). Medications decreased from 2.0 +/- 1.3 [2.0 +/- 1.3 (XEN) vs. 2.0 +/- 1.3 (Phaco+XEN)] to 0.8 +/- 1.1 [0.8 +/- 1.1 (XEN) vs. 0.8 +/- 1.1 (Phaco + XEN)] (-60%; P<0.001). Needling was performed in 84 eyes (49%), and 19.4% underwent a secondary surgical intervention. Complete success at 3 years was a strong predictor of success at 5 years (odds ratio: 3.06, P<0.01), while needling was associated with higher rates of failure (odds ratio: 3.6, P<0.01).Conclusions: At 5 years, XEN gel stent implantation was a safe procedure and achieved clinically meaningful IOP and medication reduction. Success at 3 years is a predictor of success at 5 years. Needling correlates with higher failure rates.
引用
收藏
页码:909 / 917
页数:9
相关论文
共 50 条
  • [21] One year efficacy and safety of inferior implantation of Xen 45® Gel Stent in refractory glaucoma
    Bastelica, P.
    Amatu, J. -B.
    Buffault, J.
    Majoulet, A.
    Labbe, A.
    Baudouin, C.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2024, 47 (08):
  • [22] Bilateral XEN Gel Stent Implantation in Juvenile-Onset Open-Angle Glaucoma
    Klug, Emma
    Sola-Del Valle, David
    CASE REPORTS IN OPHTHALMOLOGY, 2020, 11 (02): : 336 - 341
  • [23] Learning Curve and One-Year Outcome of XEN 45 Gel Stent Implantation in a Swedish Population
    Busch, Tobias
    Skiljic, Dragana
    Rudolph, Thiemo
    Bergstrom, Anders
    Zetterberg, Madeleine
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 3719 - 3733
  • [24] New XEN63 Gel Stent Implantation in Open-Angle Glaucoma: A Two-Year Follow-Up Pilot Study
    Voykov, Bogomil
    Nasyrov, Emil
    Neubauer, Jonas
    Gassel, Caroline J.
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 2243 - 2249
  • [25] XEN Gel Stent in Pseudoexfoliative Glaucoma: 2-Year Results of a Prospective Evaluation
    Gillmann, Kevin
    Bravetti, Giorgio E.
    Mermoud, Andre
    Rao, Harsha L.
    Mansouri, Kaweh
    JOURNAL OF GLAUCOMA, 2019, 28 (08) : 676 - 684
  • [26] Trabeculotomy (ab externo) as primary intervention for open-angle glaucoma: 5-year results
    Bornhauser, Marco
    Neuhann, Lukas
    Neuhann, Thomas
    Maier, Mathias
    OPHTHALMOLOGIE, 2024, 121 (01): : 43 - 52
  • [27] XEN Gel Stent in the management of primary open-angle glaucoma
    Post, Michal
    Lubinski, Wojciech
    Sliwiak, Dominik
    Podboruczynska-Jodko, Karolina
    Mularczyk, Maciej
    DOCUMENTA OPHTHALMOLOGICA, 2020, 141 (01) : 65 - 76
  • [28] Standalone XEN45 Gel Stent implantation versus combined XEN45-phacoemulsification in the treatment of open angle glaucoma—a systematic review and meta-analysis
    Sheng Yang Lim
    Bjorn Kaijun Betzler
    Leonard Wei Leon Yip
    Syril Dorairaj
    Bryan Chin Hou Ang
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 3209 - 3219
  • [29] XEN Gel Stent in the management of primary open-angle glaucoma
    Michał Post
    Wojciech Lubiński
    Dominik Śliwiak
    Karolina Podborączyńska-Jodko
    Maciej Mularczyk
    Documenta Ophthalmologica, 2020, 141 : 65 - 76
  • [30] Complications and post-operative interventions in XEN45 gel stent implantation in the treatment of open angle glaucoma-a systematic review and meta-analysis
    Betzler, Bjorn Kaijun
    Lim, Sheng Yang
    Lim, Boon Ang
    Yip, Vivien Cherng Hui
    Ang, Bryan Chin Hou
    EYE, 2023, 37 (06) : 1047 - 1060